Document Detail


Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.
MedLine Citation:
PMID:  20874225     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Idiopathic pulmonary fibrosis (IPF) is a devastating disease without proper treatment. Despite intensive research, the exact underlying pathogenesis remains elusive. It is regarded as a continuous injury, resulting in inflammation, infiltration, and proliferation of fibroblasts and extracellular matrix deposition, leading to an irreversible restrictive lung function deterioration and death. In this study the effect of azithromycin, a macrolide antibiotic on bleomycin-induced pulmonary fibrosis was investigated. C57BL/6 mice were intratracheally instilled with bleomycin (0.5 mg/kg) or saline. In the bleomycin group, half of the animals received azithromycin every other day from day 1 on. Bronchoalveolar lavage and histology were performed at days 7 and 35, and pulmonary function tests on day 35. At day 35, fibrotic lesions (spindle cell proliferation/collagen I deposition) were paralleled by a restrictive lung function pattern. Alterations were found in neutrophils and macrophages (innate immunity) and in T(H)2, T(H)17, and Treg cytokines (adaptive immunity). Azithromycin significantly reduced both fibrosis and the restrictive lung function pattern. This study demonstrated a beneficial effect of azithromycin on bleomycin-induced pulmonary fibrosis. A possible mechanism could be a modulation of both innate immunity and adaptive immunity. These findings might suggest a potential role for azithromycin in the treatment of IPF.
Authors:
W A Wuyts; S Willems; R Vos; B M Vanaudenaerde; S I De Vleeschauwer; M Rinaldi; H M Vanhooren; N Geudens; S E Verleden; M G Demedts; M Thomeer; E K Verbeken; G M Verleden
Related Documents :
20369035 - Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock.
11359445 - Fts reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary ...
12900275 - Cell-mediated immunity to respiratory virus infections.
11292065 - Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of prot...
2677735 - Immune response in mice infected with candida albicans in the mycelial form.
18622025 - Thrombin enhances the production of monocyte chemoattractant protein-1 and macrophage i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-27
Journal Detail:
Title:  Experimental lung research     Volume:  36     ISSN:  1521-0499     ISO Abbreviation:  Exp. Lung Res.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8004944     Medline TA:  Exp Lung Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  602-14     Citation Subset:  IM    
Affiliation:
Laboratory of Pneumology, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium. wim.wuyts@uzleuven.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pilot study of vaporization of perfluorohexane during high-frequency oscillatory ventilation in expe...
Next Document:  An attempt of postharvest orange fruit rot control using essential oils from mediterranean plants.